Papers: 11 Jul 2014 - 18 Jul 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey. Marck CH, Hadgkiss EJ, Weiland TJ, van der Meer DM, Pereira NG, Jelinek GA BMC Neurol. 2014; 14(1):143. Epub 2014 Jul 12. PMID: 25016312. Abstract Editors' Pick Detecting clinically-relevant changes in progressive multiple sclerosis. Bosma L, Sonder J, Kragt J, Polman CH, Uitdehaag BMJ Mult Scler. 2014 Jul 10. PMID: 25013153. Abstract Editors' Pick Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging. Ciccarelli O, Barkhof F, Bodini B, De Stefano N, Golay X, Nicolay K, Pelletier D, Pouwels PJW, Smith SA, Wheeler-Kingshott C A, et al. Lancet Neurol. 2014 Aug; 13(8):807-822. Epub 2014 Jul 06. PMID: 25008549. Abstract The impact of the human genome project on complex disease. Bailey J CN, Pericak-Vance MA, Haines JL Genes (Basel). 2014; 5(3):518-35. PMID: 25032678. Abstract Progressive Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by Oligodendrocytes. Bull S-J, Bin JM, Beaumont E, Boutet A, Krimpenfort P, Sadikot AF, Kennedy TE J Neurosci. 2014 Jul 16; 34(29):9768-78. PMID: 25031414. Abstract N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions. Klingener M, Chavali M, Singh J, McMillan N, Coomes A, Dempsey PJ, Chen EI, Aguirre A J Neurosci. 2014 Jul 16; 34(29):9590-606. PMID: 25031401. Abstract Age of Onset as a Moderator of Cognitive Decline in Pediatric-Onset Multiple Sclerosis. Hosseini B, Flora DB, Banwell BL, Till C J Int Neuropsychol Soc. 2014 Jul 17:1-9. PMID: 25033163. Abstract Risk of suicide and suicide attempts associated with physical disorders: a population-based, balancing score-matched analysis. Bolton JM, Walld R, Chateau D, Finlayson G, Sareen J Psychol Med. 2014 Jul 17:1-10. PMID: 25032807. Abstract Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury. Bai Q, Parris RS, Burton EA J Biol Chem. 2014 Jul 15. PMID: 25028515. Abstract Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Takizawa S, Kaneyama T, Tsugane S, Takeichi N, Yanagisawa S, Ichikawa M, Yagita H, Kim BS, Koh C-S J Neuroimmunol. 2014 Jun 27. PMID: 25027060. Abstract Clinically isolated syndromes and the relationship to multiple sclerosis. Brownlee WJ, Miller DH J Clin Neurosci. 2014 Jul 11. PMID: 25027666. Abstract Normative data and long-term test-retest reliability of the triple stimulation technique (TST) in multiple sclerosis. Hofstadt-van Oy U, Keune PM, Muenssinger J, Hagenburger D, Oschmann P Clin Neurophysiol. 2014 Jun 21. PMID: 25027641. Abstract Neuromyelitis optica spectrum disorders. Flanagan EP, Weinshenker BG Curr Neurol Neurosci Rep. 2014 Sep; 14(9):483. PMID: 25027264. Abstract Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders. Watanabe M, Kondo T, Murakata K, Kageyama T, Shibata Y, Takahashi T, Nomura K, Matsumoto S J Neuroimmunol. 2014 Jun 27. PMID: 25027061. Abstract Hemispheric asymmetry measured by texture analysis and diffusion tensor imaging in two multiple sclerosis subtypes. Savio S, Hakulinen U, Ryymin P, Hagman S, Dastidar P, Soimakallio S, Elovaara I, Eskola H Acta Radiol. 2014 Jul 14. PMID: 25024438. Abstract Myelination at a glance. Snaidero N, Simons M J Cell Sci. 2014 Jul 15; 127(Pt 14):2999-3004. PMID: 25024457. Abstract Effects of Bacille Calmette-GuÉrin after the first demyelinating event in the CNS. Sethi NK, Ristori G, Romano S, Coarelli G, Buscarinu M C, Salvetti M Neurology. 2014 Jul 15; 83(3):293. PMID: 25024446. Abstract Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis. Petek-Balcı B, Coban A, Shugaiv E, Türkoğlu R, Ulusoy C, Içöz S, Pehlivan M, Tüzün E, Akman-Demir G, Kürtüncü M, et al. Int J Neurosci. 2014 Jul 17. PMID: 25026220. Abstract Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies. Gao J, Pan W, Zhang H JAMA Neurol. 2014 Jul 1; 71(7):923-4. PMID: 25023552. Abstract Moving to fingolimod from natalizumab in multiple sclerosis-reply. Cohen M, Lebrun C JAMA Neurol. 2014 Jul 1; 71(7):925. PMID: 25023556. Abstract Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved. Bianco A, Rossini P M, Mirabella M JAMA Neurol. 2014 Jul 1; 71(7):924-5. PMID: 25023553. Abstract Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply. Kitley J, Waters P, Vincent A, Palace J JAMA Neurol. 2014 Jul 1; 71(7):924. PMID: 25023554. Abstract Single nucleotide polymorphisms with cis-regulatory effects on long non-coding transcripts in human primary monocytes. Carlsson Almlöf J, Lundmark P, Lundmark A, Ge B, Pastinen T, Cardiogenics Consortium, Goodall AH, Cambien F, Deloukas P, Ouwehand WH, et al. PLoS One. 2014; 9(7):e102612. Epub 2014 Jul 15. PMID: 25025429. Abstract Gene expression profiling of the response to interferon Beta in epstein-barr-transformed and primary B cells of patients with multiple sclerosis. Khsheibun R, Paperna T, Volkowich A, Lejbkowicz I, Avidan N, Miller A PLoS One. 2014; 9(7):e102331. Epub 2014 Jul 15. PMID: 25025430. Abstract Both positive and negative effects on immune responses by expression of a second class II MHC molecule. Ni PP, Wang Y, Allen PM Mol Immunol. 2014 Jul 10; 62(1):199-208. PMID: 25016574. Abstract Human endogenous retroviruses and the nervous system. Douville RN, Nath A Handb Clin Neurol. 2014; 123:465-85. PMID: 25015500. Abstract Regulatory B cells, helminths, and multiple sclerosis. Correale J, Equiza T R Methods Mol Biol. 2014; 1190:257-69. PMID: 25015286. Abstract Gene therapy with Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis. Talla V, Porciatti V, Chiodo VA, Boye SL, Hauswirth WW, Guy J Invest Ophthalmol Vis Sci. 2014 Jul 11. PMID: 25015358. Abstract Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review. Crescentini C, Urgesi C, Fabbro F, Eleopra R Restor Neurol Neurosci. 2014 Jul 11. PMID: 25015704. Abstract Regulatory B Cells in Experimental Autoimmune Encephalomyelitis (EAE). Ray A, Basu S Methods Mol Biol. 2014; 1190:243-55. PMID: 25015285. Abstract ▼Teriflunomide for multiple sclerosis. Drug Ther Bull. 2014 Jul; 52(7):81-4. PMID: 25012149. Abstract Aquaporin-4 autoimmunity masquerading as a brainstem tumor. Lim B C, Chae J H, Kim S-K, Park S-H, Wang K-C, Lee J Y, Phi J H J Neurosurg Pediatr. 2014 Jul 11:1-5. PMID: 25014325. Abstract Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats. Yin L, Chen Y, Qu Z, Zhang L, Wang Q, Zhang Q, Li L J Neuroimmunol. 2014 Jun 28. PMID: 25012120. Abstract Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome. Lee J, Jeong S-H, Park S M, Sohn E H, Lee A Y, Kim J-M, Jo H-J, Lee Y-H, Kim J-S Mult Scler. 2014 Jul 10. PMID: 25013154. Abstract The impact of neuromyelitis optica on the recognition of emotional facial expressions: A preliminary report. Cardona JF, Sinay V, Amoruso L, Hesse E, Manes F, Ibáñez A Soc Neurosci. 2014 Jul 11:1-6. PMID: 25012679. Abstract The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results. Ploughman M, Beaulieu S, Harris C, Hogan S, Manning OJ, Alderdice PW, Fisk JD, Sadovnick DA, O'Connor P, Morrow SA, et al. BMJ Open. 2014; 4(7):e005718. PMID: 25011993. Abstract The visual pathway as a model to understand brain damage in multiple sclerosis. Martínez-Lapiscina E, Sanchez-Dalmau B, Fraga-Pumar E, Ortiz-Perez S, Tercero-Uribe A, Torres-Torres R, Villoslada P Mult Scler. 2014 Jul 10. PMID: 25013155. Abstract Recognising and diagnosing inflammatory brain disease. Scolding N J Neurol Neurosurg Psychiatry. 2014 Aug; 85(8):e3. PMID: 25009322. Abstract The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages. Ottow MK, Klaver EJ, van der Pouw Kraan TCTM, Heijnen PD, Laan LC, Kringel H, Vogel DYS, Dijkstra C, Kooij G, van Die I Genes Immun. 2014 Jul 10. PMID: 25008860. Abstract [Multiple sclerosis, neuromyelitis optica and spasticity: control of specific symptoms and quality of life]. Patejdl R, Tesar S, Zettl UK Fortschr Neurol Psychiatr. 2014 Jul; 82(7):373-85. Epub 2014 Jul 11. PMID: 25014200. Abstract Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort. Johansson V, Lundholm C, Hillert J, Masterman T, Lichtenstein P, Landén M, Hultman CM Mult Scler. 2014 Jul 10. Epub 2014 Jul 10. PMID: 25013151. Abstract Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration? Kilsdonk ID, Steenwijk MD, Pouwels PJW, Zwanenburg JJM, Visser F, Luijten PR, Geurts JJG, Barkhof F, Wattjes MP Mult Scler. 2014 Jul 10. Epub 2014 Jul 10. PMID: 25013150. Abstract Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang M-H, Chen A-P, et al. Lancet Neurol. 2014 Aug; 13(8):795-806. Epub 2014 Jul 06. PMID: 25008548. Abstract Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod. Correale J, Chiquete E, Milojevic S, Frider N, Bajusz I Drug Des Devel Ther. 2014; 8:859-67. Epub 2014 Jun 25. PMID: 25028537. Abstract Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation. Chen C-C, Lin J-T, Cheng Y-F, Kuo C-Y, Huang C-F, Kao S-H, Liang Y-J, Cheng C-Y, Chen H-M Biomed Res Int. 2014; 2014:692061. Epub 2014 Jun 17. PMID: 25025067. Abstract The squares test as a measure of hand function in multiple sclerosis. Gielen J, Laton J, Van Schependom J, De Deyn PP, Nagels G Clin Neurol Neurosurg. 2014 Aug; 123:55-60. Epub 2014 May 20. PMID: 25012012. Abstract Wheelchair design for people with neuromuscular disability. Nitz JC, Bullock MI Aust J Physiother. 1983 Apr; 29(2):43-7. Epub 2014 Mar 27. PMID: 25025172. Abstract A facilitation and co-ordination therapy approach to the treatment of multiple sclerosis. Marcham G Aust J Physiother. 1974 Mar; 20(1):23-5. Epub 2014 Mar 27. PMID: 25026145. Abstract Claudin Proteins And Neuronal Function. Devaux J, Fykkolodziej B, Gow A Curr Top Membr. 2010; 65:229-253. PMID: 25013353. Abstract
Editors' Pick Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey. Marck CH, Hadgkiss EJ, Weiland TJ, van der Meer DM, Pereira NG, Jelinek GA BMC Neurol. 2014; 14(1):143. Epub 2014 Jul 12. PMID: 25016312. Abstract
Editors' Pick Detecting clinically-relevant changes in progressive multiple sclerosis. Bosma L, Sonder J, Kragt J, Polman CH, Uitdehaag BMJ Mult Scler. 2014 Jul 10. PMID: 25013153. Abstract
Editors' Pick Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging. Ciccarelli O, Barkhof F, Bodini B, De Stefano N, Golay X, Nicolay K, Pelletier D, Pouwels PJW, Smith SA, Wheeler-Kingshott C A, et al. Lancet Neurol. 2014 Aug; 13(8):807-822. Epub 2014 Jul 06. PMID: 25008549. Abstract
The impact of the human genome project on complex disease. Bailey J CN, Pericak-Vance MA, Haines JL Genes (Basel). 2014; 5(3):518-35. PMID: 25032678. Abstract
Progressive Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by Oligodendrocytes. Bull S-J, Bin JM, Beaumont E, Boutet A, Krimpenfort P, Sadikot AF, Kennedy TE J Neurosci. 2014 Jul 16; 34(29):9768-78. PMID: 25031414. Abstract
N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions. Klingener M, Chavali M, Singh J, McMillan N, Coomes A, Dempsey PJ, Chen EI, Aguirre A J Neurosci. 2014 Jul 16; 34(29):9590-606. PMID: 25031401. Abstract
Age of Onset as a Moderator of Cognitive Decline in Pediatric-Onset Multiple Sclerosis. Hosseini B, Flora DB, Banwell BL, Till C J Int Neuropsychol Soc. 2014 Jul 17:1-9. PMID: 25033163. Abstract
Risk of suicide and suicide attempts associated with physical disorders: a population-based, balancing score-matched analysis. Bolton JM, Walld R, Chateau D, Finlayson G, Sareen J Psychol Med. 2014 Jul 17:1-10. PMID: 25032807. Abstract
Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury. Bai Q, Parris RS, Burton EA J Biol Chem. 2014 Jul 15. PMID: 25028515. Abstract
Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Takizawa S, Kaneyama T, Tsugane S, Takeichi N, Yanagisawa S, Ichikawa M, Yagita H, Kim BS, Koh C-S J Neuroimmunol. 2014 Jun 27. PMID: 25027060. Abstract
Clinically isolated syndromes and the relationship to multiple sclerosis. Brownlee WJ, Miller DH J Clin Neurosci. 2014 Jul 11. PMID: 25027666. Abstract
Normative data and long-term test-retest reliability of the triple stimulation technique (TST) in multiple sclerosis. Hofstadt-van Oy U, Keune PM, Muenssinger J, Hagenburger D, Oschmann P Clin Neurophysiol. 2014 Jun 21. PMID: 25027641. Abstract
Neuromyelitis optica spectrum disorders. Flanagan EP, Weinshenker BG Curr Neurol Neurosci Rep. 2014 Sep; 14(9):483. PMID: 25027264. Abstract
Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders. Watanabe M, Kondo T, Murakata K, Kageyama T, Shibata Y, Takahashi T, Nomura K, Matsumoto S J Neuroimmunol. 2014 Jun 27. PMID: 25027061. Abstract
Hemispheric asymmetry measured by texture analysis and diffusion tensor imaging in two multiple sclerosis subtypes. Savio S, Hakulinen U, Ryymin P, Hagman S, Dastidar P, Soimakallio S, Elovaara I, Eskola H Acta Radiol. 2014 Jul 14. PMID: 25024438. Abstract
Myelination at a glance. Snaidero N, Simons M J Cell Sci. 2014 Jul 15; 127(Pt 14):2999-3004. PMID: 25024457. Abstract
Effects of Bacille Calmette-GuÉrin after the first demyelinating event in the CNS. Sethi NK, Ristori G, Romano S, Coarelli G, Buscarinu M C, Salvetti M Neurology. 2014 Jul 15; 83(3):293. PMID: 25024446. Abstract
Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis. Petek-Balcı B, Coban A, Shugaiv E, Türkoğlu R, Ulusoy C, Içöz S, Pehlivan M, Tüzün E, Akman-Demir G, Kürtüncü M, et al. Int J Neurosci. 2014 Jul 17. PMID: 25026220. Abstract
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies. Gao J, Pan W, Zhang H JAMA Neurol. 2014 Jul 1; 71(7):923-4. PMID: 25023552. Abstract
Moving to fingolimod from natalizumab in multiple sclerosis-reply. Cohen M, Lebrun C JAMA Neurol. 2014 Jul 1; 71(7):925. PMID: 25023556. Abstract
Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved. Bianco A, Rossini P M, Mirabella M JAMA Neurol. 2014 Jul 1; 71(7):924-5. PMID: 25023553. Abstract
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply. Kitley J, Waters P, Vincent A, Palace J JAMA Neurol. 2014 Jul 1; 71(7):924. PMID: 25023554. Abstract
Single nucleotide polymorphisms with cis-regulatory effects on long non-coding transcripts in human primary monocytes. Carlsson Almlöf J, Lundmark P, Lundmark A, Ge B, Pastinen T, Cardiogenics Consortium, Goodall AH, Cambien F, Deloukas P, Ouwehand WH, et al. PLoS One. 2014; 9(7):e102612. Epub 2014 Jul 15. PMID: 25025429. Abstract
Gene expression profiling of the response to interferon Beta in epstein-barr-transformed and primary B cells of patients with multiple sclerosis. Khsheibun R, Paperna T, Volkowich A, Lejbkowicz I, Avidan N, Miller A PLoS One. 2014; 9(7):e102331. Epub 2014 Jul 15. PMID: 25025430. Abstract
Both positive and negative effects on immune responses by expression of a second class II MHC molecule. Ni PP, Wang Y, Allen PM Mol Immunol. 2014 Jul 10; 62(1):199-208. PMID: 25016574. Abstract
Human endogenous retroviruses and the nervous system. Douville RN, Nath A Handb Clin Neurol. 2014; 123:465-85. PMID: 25015500. Abstract
Regulatory B cells, helminths, and multiple sclerosis. Correale J, Equiza T R Methods Mol Biol. 2014; 1190:257-69. PMID: 25015286. Abstract
Gene therapy with Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis. Talla V, Porciatti V, Chiodo VA, Boye SL, Hauswirth WW, Guy J Invest Ophthalmol Vis Sci. 2014 Jul 11. PMID: 25015358. Abstract
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review. Crescentini C, Urgesi C, Fabbro F, Eleopra R Restor Neurol Neurosci. 2014 Jul 11. PMID: 25015704. Abstract
Regulatory B Cells in Experimental Autoimmune Encephalomyelitis (EAE). Ray A, Basu S Methods Mol Biol. 2014; 1190:243-55. PMID: 25015285. Abstract
▼Teriflunomide for multiple sclerosis. Drug Ther Bull. 2014 Jul; 52(7):81-4. PMID: 25012149. Abstract
Aquaporin-4 autoimmunity masquerading as a brainstem tumor. Lim B C, Chae J H, Kim S-K, Park S-H, Wang K-C, Lee J Y, Phi J H J Neurosurg Pediatr. 2014 Jul 11:1-5. PMID: 25014325. Abstract
Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats. Yin L, Chen Y, Qu Z, Zhang L, Wang Q, Zhang Q, Li L J Neuroimmunol. 2014 Jun 28. PMID: 25012120. Abstract
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome. Lee J, Jeong S-H, Park S M, Sohn E H, Lee A Y, Kim J-M, Jo H-J, Lee Y-H, Kim J-S Mult Scler. 2014 Jul 10. PMID: 25013154. Abstract
The impact of neuromyelitis optica on the recognition of emotional facial expressions: A preliminary report. Cardona JF, Sinay V, Amoruso L, Hesse E, Manes F, Ibáñez A Soc Neurosci. 2014 Jul 11:1-6. PMID: 25012679. Abstract
The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results. Ploughman M, Beaulieu S, Harris C, Hogan S, Manning OJ, Alderdice PW, Fisk JD, Sadovnick DA, O'Connor P, Morrow SA, et al. BMJ Open. 2014; 4(7):e005718. PMID: 25011993. Abstract
The visual pathway as a model to understand brain damage in multiple sclerosis. Martínez-Lapiscina E, Sanchez-Dalmau B, Fraga-Pumar E, Ortiz-Perez S, Tercero-Uribe A, Torres-Torres R, Villoslada P Mult Scler. 2014 Jul 10. PMID: 25013155. Abstract
Recognising and diagnosing inflammatory brain disease. Scolding N J Neurol Neurosurg Psychiatry. 2014 Aug; 85(8):e3. PMID: 25009322. Abstract
The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages. Ottow MK, Klaver EJ, van der Pouw Kraan TCTM, Heijnen PD, Laan LC, Kringel H, Vogel DYS, Dijkstra C, Kooij G, van Die I Genes Immun. 2014 Jul 10. PMID: 25008860. Abstract
[Multiple sclerosis, neuromyelitis optica and spasticity: control of specific symptoms and quality of life]. Patejdl R, Tesar S, Zettl UK Fortschr Neurol Psychiatr. 2014 Jul; 82(7):373-85. Epub 2014 Jul 11. PMID: 25014200. Abstract
Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort. Johansson V, Lundholm C, Hillert J, Masterman T, Lichtenstein P, Landén M, Hultman CM Mult Scler. 2014 Jul 10. Epub 2014 Jul 10. PMID: 25013151. Abstract
Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration? Kilsdonk ID, Steenwijk MD, Pouwels PJW, Zwanenburg JJM, Visser F, Luijten PR, Geurts JJG, Barkhof F, Wattjes MP Mult Scler. 2014 Jul 10. Epub 2014 Jul 10. PMID: 25013150. Abstract
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang M-H, Chen A-P, et al. Lancet Neurol. 2014 Aug; 13(8):795-806. Epub 2014 Jul 06. PMID: 25008548. Abstract
Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod. Correale J, Chiquete E, Milojevic S, Frider N, Bajusz I Drug Des Devel Ther. 2014; 8:859-67. Epub 2014 Jun 25. PMID: 25028537. Abstract
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation. Chen C-C, Lin J-T, Cheng Y-F, Kuo C-Y, Huang C-F, Kao S-H, Liang Y-J, Cheng C-Y, Chen H-M Biomed Res Int. 2014; 2014:692061. Epub 2014 Jun 17. PMID: 25025067. Abstract
The squares test as a measure of hand function in multiple sclerosis. Gielen J, Laton J, Van Schependom J, De Deyn PP, Nagels G Clin Neurol Neurosurg. 2014 Aug; 123:55-60. Epub 2014 May 20. PMID: 25012012. Abstract
Wheelchair design for people with neuromuscular disability. Nitz JC, Bullock MI Aust J Physiother. 1983 Apr; 29(2):43-7. Epub 2014 Mar 27. PMID: 25025172. Abstract
A facilitation and co-ordination therapy approach to the treatment of multiple sclerosis. Marcham G Aust J Physiother. 1974 Mar; 20(1):23-5. Epub 2014 Mar 27. PMID: 25026145. Abstract
Claudin Proteins And Neuronal Function. Devaux J, Fykkolodziej B, Gow A Curr Top Membr. 2010; 65:229-253. PMID: 25013353. Abstract